Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.84 | N/A |
| PEG Ratio (TTM) | -0.86 | N/A |
| P/S Ratio (TTM) | 0.72 | N/A |
| P/B Ratio (TTM) | 1.34 | N/A |
| P/FCF Ratio (TTM) | 9.93 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.14 | N/A |
| Price to 5YR AVG FCF Ratio | 12.92 | N/A |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.12% | N/A |
| ROE (TTM) | 11.42% | N/A |
| Net Profit Margin (TTM) | 6.13% | N/A |
| ROIC 5YR AVG | 22.51% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.97% | 93.36% | 41.98% |
| Revenue | -2.14% | 16.43% | 7.62% |
| Net Income | -7.36% | 94.55% | 42.15% |
| Cash Flow | 24.52% | 724.52% | 446.48% |
Health (86%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.94 | N/A |
| Quick Ratio (TTM) | 2.78 | N/A |
| D/E Ratio (TTM) | 0.28 | N/A |
| Interest Coverage (TTM) | 14.86 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 4.21 | N/A |
| LTL to 5YR AVG FCF | 2.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.33% | N/A |